Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1942 1
1946 1
1947 1
1948 2
1952 1
1955 3
1956 1
1957 3
1958 3
1959 1
1960 5
1961 1
1962 4
1963 3
1964 6
1965 3
1966 3
1967 3
1968 5
1969 5
1970 3
1971 7
1972 3
1973 10
1974 16
1975 10
1976 7
1977 17
1978 7
1979 14
1980 14
1981 19
1982 14
1983 19
1984 30
1985 13
1986 19
1987 14
1988 17
1989 11
1990 14
1991 15
1992 11
1993 11
1994 13
1995 11
1996 12
1997 14
1998 14
1999 13
2000 23
2001 19
2002 25
2003 26
2004 24
2005 38
2006 42
2007 42
2008 39
2009 41
2010 41
2011 52
2012 45
2013 60
2014 60
2015 57
2016 61
2017 62
2018 84
2019 106
2020 108
2021 134
2022 92
Text availability
Article attribute
Article type
Publication date

Search Results

1,577 results
Results by year
Filters applied: . Clear all
Page 1
The Crosstalk Between Hippo-YAP Pathway and Innate Immunity.
Wang S, Zhou L, Ling L, Meng X, Chu F, Zhang S, Zhou F. Wang S, et al. Among authors: chu f. Front Immunol. 2020 Feb 27;11:323. doi: 10.3389/fimmu.2020.00323. eCollection 2020. Front Immunol. 2020. PMID: 32174922 Free PMC article. Review.
Gut microbiota impact on the peripheral immune response in non-alcoholic fatty liver disease related hepatocellular carcinoma.
Behary J, Amorim N, Jiang XT, Raposo A, Gong L, McGovern E, Ibrahim R, Chu F, Stephens C, Jebeili H, Fragomeli V, Koay YC, Jackson M, O'Sullivan J, Weltman M, McCaughan G, El-Omar E, Zekry A. Behary J, et al. Among authors: chu f. Nat Commun. 2021 Jan 8;12(1):187. doi: 10.1038/s41467-020-20422-7. Nat Commun. 2021. PMID: 33420074 Free PMC article.
PICO: What it is and what it is not.
Schiavenato M, Chu F. Schiavenato M, et al. Among authors: chu f. Nurse Educ Pract. 2021 Oct;56:103194. doi: 10.1016/j.nepr.2021.103194. Epub 2021 Sep 2. Nurse Educ Pract. 2021. PMID: 34534728 Review.
Transcriptional regulatory model of fibrosis progression in the human lung.
McDonough JE, Ahangari F, Li Q, Jain S, Verleden SE, Herazo-Maya J, Vukmirovic M, DeIuliis G, Tzouvelekis A, Tanabe N, Chu F, Yan X, Verschakelen J, Homer RJ, Manatakis DV, Zhang J, Ding J, Maes K, De Sadeleer L, Vos R, Neyrinck A, Benos PV, Bar-Joseph Z, Tantin D, Hogg JC, Vanaudenaerde BM, Wuyts WA, Kaminski N. McDonough JE, et al. Among authors: chu f. JCI Insight. 2019 Nov 14;4(22):e131597. doi: 10.1172/jci.insight.131597. JCI Insight. 2019. PMID: 31600171 Free PMC article.
CD19 target evasion as a mechanism of relapse in large B-cell lymphoma treated with axicabtagene ciloleucel.
Plaks V, Rossi JM, Chou J, Wang L, Poddar S, Han G, Wang Z, Kuang SQ, Chu F, Davis RE, Vega F, Bashir Z, Jacobson CA, Locke FL, Reagan PM, Rodig SJ, Lekakis LJ, Flinn IW, Miklos DB, Bot A, Neelapu SS. Plaks V, et al. Among authors: chu f. Blood. 2021 Sep 23;138(12):1081-1085. doi: 10.1182/blood.2021010930. Blood. 2021. PMID: 34041526 Free PMC article. Clinical Trial. No abstract available.
1,577 results